These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 28280192)

  • 1. Exploiting cancer metabolism.
    Chong LD
    Science; 2017 Mar; 355(6329):1036. PubMed ID: 28280192
    [No Abstract]   [Full Text] [Related]  

  • 2. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
    Hay N
    Nat Rev Cancer; 2016 Oct; 16(10):635-49. PubMed ID: 27634447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting glycogen metabolism in bladder cancer.
    Ritterson Lew C; Guin S; Theodorescu D
    Nat Rev Urol; 2015 Jul; 12(7):383-91. PubMed ID: 26032551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regularity in the pattern of the metabolic reaction network].
    Malygin AG
    Biokhimiia; 1989 Jun; 54(6):883-94. PubMed ID: 2790076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting hypoxia in solid tumors to achieve oncolysis.
    Payne AG
    Med Hypotheses; 2007; 68(4):828-31. PubMed ID: 17055180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.
    Pikor LA; Bell JC; Diallo JS
    Trends Cancer; 2015 Dec; 1(4):266-277. PubMed ID: 28741515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting nanotechnology to target cancer.
    Sengupta S; Sasisekharan R
    Br J Cancer; 2007 May; 96(9):1315-9. PubMed ID: 17406364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting LKB1 in cancer - exposing and exploiting vulnerabilities.
    Momcilovic M; Shackelford DB
    Br J Cancer; 2015 Aug; 113(4):574-84. PubMed ID: 26196184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells.
    Venturelli L; Nappini S; Bulfoni M; Gianfranceschi G; Dal Zilio S; Coceano G; Del Ben F; Turetta M; Scoles G; Vaccari L; Cesselli D; Cojoc D
    Sci Rep; 2016 Feb; 6():21629. PubMed ID: 26899926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The compositional and evolutionary logic of metabolism.
    Braakman R; Smith E
    Phys Biol; 2013 Feb; 10(1):011001. PubMed ID: 23234798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiting for cancer care: exploiting our national laboratory.
    Sullivan T
    Can J Surg; 2006 Feb; 49(1):12-4. PubMed ID: 16524136
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional consequences of perturbing polyamine metabolism in the malaria parasite, Plasmodium falciparum.
    Clark K; Niemand J; Reeksting S; Smit S; van Brummelen AC; Williams M; Louw AI; Birkholtz L
    Amino Acids; 2010 Feb; 38(2):633-44. PubMed ID: 19997948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting combinatorial patterns in cancer genomic data for personalized therapy and new target discovery.
    Schubert M; Iorio F
    Pharmacogenomics; 2014 Dec; 15(16):1943-6. PubMed ID: 25521353
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy.
    Nomikou N; McHale AP
    Cancer Lett; 2010 Oct; 296(2):133-43. PubMed ID: 20598800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(+)-specific glutamate dehydrogenase (EC.1.4.1.2) in Streptomyces coelicolor; in vivo characterization and the implication for nutrient-dependent secondary metabolism.
    Kim SH; Kim BG
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5527-36. PubMed ID: 26969038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: potential clinical use of exploiting metastasis suppressor genes to regulate prostatic cancer.
    Hendrix MJ
    J Urol; 2003 Mar; 169(3):1134. PubMed ID: 12576867
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma.
    Dranoff G; Elion GB; Friedman HS; Bigner DD
    Cancer Res; 1985 Sep; 45(9):4082-6. PubMed ID: 4028000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energetic metabolism of Chromobacterium violaceum.
    Creczynski-Pasa TB; Antônio RV
    Genet Mol Res; 2004 Mar; 3(1):162-6. PubMed ID: 15100996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting liver immunity for the prevention of hepatic metastases.
    Rivoltini L; Mazzaferro V
    J Hepatol; 2010 Oct; 53(4):596-8. PubMed ID: 20609489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.